Development and validation of an ion-pair HPLC chromatography for simultaneous determination of lactone and carboxylate forms of SN-38 in nanoparticles

Journal of Food and Drug Analysis

Volumn 17, Issue 4, 2009, Pages

  Ebrahimnejad, Pedram ^a,b,e   Dinarvand, Rassoul ^a,d   Sajadi, Abolghasem ^b   Jafari, Mahmoud Reza ^c   Movaghari, Farshid ^e   Atyabi, Fatemeh ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Quality Control Department   (Iran)

Author keywords

HPLC; Ion pair; Irinotecan; Nanoparticles; SN 38

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ACETONITRILE; CARBOXYLIC ACID; LACTONE; NANOPARTICLE; POLYGLACTIN;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STRUCTURE; FLOW RATE; ION PAIR CHROMATOGRAPHY; LIGHT ABSORPTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

EID: 70350704689     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Onishi, H. and Machida, Y. 2003. Antitumor properties of irinotecan-containing nanoparticles prepared using poly (DL-lactic acid) and poly (ethylene glycol)-block-poly (propylene glycol)-block-poly (ethylene glycol). Biol. Pharm. Bull. 26: 116-119.
2. Rohit, B., Kolhatkar, P. S. and Hamidreza, G. 2008. Potential oral delivery of 7-ethyl-10-hydroxy-camptothecin (SN-38) using Poly (amidoamine) dendrimers. Pharm. Res. 10: 9572-9579.
3. Ebrahimnejad, P., Dinarvand, R., Sajadi, S. A., Atyabi, F., Ramezani, F. and Jaafari, M. R. 2009. Preparation and characterization of poly lactide-co-glycolide nanoparticles of SN-38. PDA J. Pharm. Sci. Technol. (Accepted)
4. Gupta, E., Lestingi, T. M., Mick, R., Ramirez, J., Vokes, E. E. and Ratain, M. J. 1994. Metabolic fate of Irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res. 54: 3723-3725. (Pubitemid 24241187)
5. Ohe, Y., Sasaki, Y., Shinkai, T., Eguchi, K., Tamura, T., Kojima, A., Kunikane, H., Okamoto, H., Karato, A. and Ohmatsu, H. 1992. Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion. J. Natl. Cancer Inst. 84: 972-974.
6. Takimoto, C. H. and Arbuck, S. G. 2001. Topoisomerase I targeting agents: the camptothecins. In: "Cancer Chemotherapy and Biotherapy: Principles and Practice" 3rd ed. pp. 579-646. Chabner, B. A. Longo, D. L. ed. Lippincott William & Wilkns. Philadelphia, U.S.A.
7. Kunii, R., Onishi, H., Ueki, K., Koyama, K. and Machida, Y. 2008. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles. Drug Deliv. 15: 3-10.
8. Esmaeili, F., Hosseini-Nasr, M., Rad-Malekshahi, M., Samadi, N., Atyabi, F. and Dinarvand, R. 2007. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine 3: 161-167.
9. Sano, K., Yoshikawa, M., Hayasaka, S., Satake, K., Ikegami, Y., Yoshida, H., Ishikawa, T. and Tanabe, S. 2003. Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of C and L forms of 14 new camptothecin derivatives J. Chromatogr. B 795: 25-34.
10. Oguma, T. 2001. Antitumor drug processing topoisomerase I inhibition: applicable separation methods. J. Chromatogr. B 764: 49-58.
11. Rivory, L. P., Findlay, M., Clarke, S. and Bishop, J. 1998. Trace analysis of SN-38 in human plasma by high-performance liquid chromatography. J. Chromatogr. B 714: 355-359.
12. Chollet, D. F., Goumaz, L., Renard, A., Montay, G., Vernillet, L., Arnera, V. and Mazzo, D. J. 1998. Simultaneous determination of the L and C forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography J. Chromatogr. B 718: 163-175. (Pubitemid 28477589)
13. Xuan, T., Allen Zhang, J. and Ahmad, I. 2006. HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN38. J. Pharm. Biomed. Anal. 41: 582-588.
14. Khan, S., Ahmad, A., Guo, W., Wang, Y. F., Abu-Qare, A. and Ahmad, I. 2005. A simple and sensitive LC/MS/MS assay for 7-ethyl-10-hydroxycamptothecin (SN-38) in mouse plasma and tissues: application to pharmacokinetic study of liposome entrapped SN-38(LE-SN38) J. Pharm. Biomed. Anal. 37: 135-142.
15. Yang, X., Hu, Z., Chan, S. Y., Goh, B. C., Duan, W., Chan, E. and Zhou, S. 2005. Simultaneous determination of the L and C forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat. J. Chromatogr. B 821: 221-228. (Pubitemid 40827031)
16. Poujol, S., Pinguet, F., Malossa, F., Astre, C., Ychou, M., Culine, S. and Bressolle, F. 2003. Sensitive HPLC-fluorescence method for irinotecan and four major metabolites in human plasma and saliva: application to pharmacokinetic studies. Clin. Chem. 49: 1900-1908.
17. Owens, T. S., Dodds, H., Fricke, K., Hanna, S. K. and Crews, K. R. 2003. High-performance liquid chromatographic assay with fluorescence detection for the simultaneous measurement of C and L forms of irinotecan and three metabolites in human plasma. J. Chromatogr. B 788: 65-74. (Pubitemid 36369111)
18. Schoemaker, N. E., Rosing, H., Jansen, S., Schellens, J. H. M. and Beijnen, J. H. 2003. High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma. Ther. Drug Monit. 25: 120-124.
19. Boyd, G., Smyth, J. F., Jodrell, D. I. and Cummings, J. 2001. High-performance liquid chromatographic technique for the simultaneous determination of L and hydroxy acid forms of camptothecin and SN-38 in tissue culture media and cancer cells. Anal. Biochem. 297: 15-24.
20. Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R. and Rudzinski, W. E. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control Release 70: 1-20. (Pubitemid 32144788)
21. Rockville, M. D. 2008. Validation of compendial methods. United States Pharmacopeia 31.
22. International Conference on Harmonization, ICH. 2008. Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedures. Geneva.
23. Wang, L. H., Hsu, K. Y., Hsu, F. L. and Lin, S. J. 2008. Simultaneous determination of caffeic acid, ferulic acid and isoferulic acid in rabbit plasma by high performance liquid chromatography. J. Food Drug Anal. 16: 34-40.
24. Yau, W. P., Vathsala, A., Lou, H. X. and Chan, E. 2004. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. J. Chromatogr. B 805: 101-112. (Pubitemid 38534408)
25. Mohammadi, A., Rezanour, N., Ansari Dogaheh, M., Ghorbani Bidkorbeh, F., Hashem, M. and Walker, R. B. 2007. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. J. Chromatogr. B 846: 215-221. (Pubitemid 46149520)